MYP_070740
Basic Information
Brevibacillin
Antimicrobial
Standard
13 amino acids
C75H134N16O16
Standard
Sequence
TLKIIVKVVKYLV
Physicochemical Analysis
1515.96 Da
10.00
2.39
2.20
0.1842
1.52
0.71
0.38
-21.32
209.23
0.0769
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
531.04
0.74
19.0
19.0
52.0
107.0
1.0
12.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0122883 VERIFIED: YES
Provenance & Taxonomy
Brevibacillus laterosporus [Bacterium]
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Lipidation
APD analysis reveals this sequence is most similar (92.31%) to Bogorol L Sequence similarity: Leu2 in brevibacillin is replaced by Val2 in bogorol K. Chemical modification: T1 dehydrated (XXW); K3=ornithine; N-terminus is acylated with 2-hydroxy-3-methylvaleric acid (lipo)
Bio-Activity Profile
Antimicrobial
Bacillus cereus ATCC 14579
1.0 μg/mL
MIC
RECORD: Rec_0123196 VERIFIED: YES
Provenance & Taxonomy
Brevibacillus laterosporus [Bacterium]
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Lipidation
APD analysis reveals this sequence is most similar (92.31%) to Bogorol L Sequence similarity: Leu2 in brevibacillin is replaced by Val2 in bogorol K. Chemical modification: T1 dehydrated (XXW); K3=ornithine; N-terminus is acylated with 2-hydroxy-3-methylvaleric acid (lipo)
Bio-Activity Profile
Antimicrobial
Klebsiella pneumoniae LMG20218
32 μg/mL
MIC
RECORD: Rec_0124288 VERIFIED: YES
Provenance & Taxonomy
Brevibacillus laterosporus [Bacterium]
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Lipidation
APD analysis reveals this sequence is most similar (92.31%) to Bogorol L Sequence similarity: Leu2 in brevibacillin is replaced by Val2 in bogorol K. Chemical modification: T1 dehydrated (XXW); K3=ornithine; N-terminus is acylated with 2-hydroxy-3-methylvaleric acid (lipo)
Bio-Activity Profile
Antimicrobial
Acinetobacter baumannii ATCC 17978
32 μg/mL
MIC
RECORD: Rec_0267277 VERIFIED: YES
Provenance & Taxonomy
Brevibacillus laterosporus [Bacterium]
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Lipidation
APD analysis reveals this sequence is most similar (92.31%) to Bogorol L Sequence similarity: Leu2 in brevibacillin is replaced by Val2 in bogorol K. Chemical modification: T1 dehydrated (XXW); K3=ornithine; N-terminus is acylated with 2-hydroxy-3-methylvaleric acid (lipo)
Bio-Activity Profile
Antimicrobial
Enterococcus faecalis ATCC 51299 anti-VRE
4-8 μg/mL
MIC
RECORD: Rec_0271189 VERIFIED: YES
Provenance & Taxonomy
Brevibacillus laterosporus [Bacterium]
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Lipidation
APD analysis reveals this sequence is most similar (92.31%) to Bogorol L Sequence similarity: Leu2 in brevibacillin is replaced by Val2 in bogorol K. Chemical modification: T1 dehydrated (XXW); K3=ornithine; N-terminus is acylated with 2-hydroxy-3-methylvaleric acid (lipo)
Bio-Activity Profile
Antimicrobial
P. syringae pv. antirrhini LMG2131, P. syringae pv. tomato DC3000
8-16 μg/mL
MIC
Showing 5 records on this page · Page 3 of 6